Skip to content

BRAVO study: Bladderscan validation study for asymptomatic postpartum urinary retention

BRAVO study: Bladderscan validation study for asymptomatic postpartum urinary retention - BRAVO study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON37324
Enrollment
1000
Registered
2012-02-03
Start date
2012-02-15
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asymptomatic postpartum urinary retention

Interventions

None listed

Sponsors

Catharina-ziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Women >= 18 years after vaginal delivery

Exclusion criteria

Exclusion criteria: women

Design outcomes

Primary

MeasureTime frame
Reliability of the Bladderscan

Secondary

MeasureTime frame
1. Prevalence of asymptomatic postpartum urinary retention 2. Risk profile for asymptomatic postpartum urinary retention

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)